ANFLEKITUG
UNII ZB82BW7AHP

Substance Identification & Data

This profile provides standardized clinical and technical data for Anflekitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZB82BW7AHP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3031358-45-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ZB82BW7AHP

CAS Registry Number

3031358-45-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ANFLEKITUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C223270

National Cancer Institute reference terminology for clinical and research data.

INN ID

13698

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Anflekitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ANFLEKITUG

Common Names & Synonyms

ANFLEKITUG [INN]

H-GAMMA1 HEAVY CHAIN (1-448) (VH MUSMUS/HOMSAP (MUS MUSCULUS IGHV1-36*03 (78.6%) -(IGHD) -IGHJ2*01 (100%)/HOMO SAPIENS IGHV1-46*01 (74.5%) -(IGHD) -IGHJ4*01 (84.6%) L123>T (113), V124>L (114), CDR-IMGT (8.8.11) (26-33.51-58.97-107)) (1-118) -HOMO SAPIENS IGHG1*03V (100%) G1M3>G1M17, NG1M1 CH1 K120, CH3 E12, M14 (CH1 R120>K (215) (119-216), HINGE 1-15 (217-231), CH2 (232-341), CH3 E12 (357), M14 (359) (342-446), CHS (447-448)) (119-448)), (221-213')-DISULFIDE WITH L-KAPPA LIGHT CHAIN (1'-213') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV4-57*01 (83.2%) -IGKJ1*01 (100%)/HOMO SAPIENS IGKV3D-11*02 (76.9%) -IGKJ4*01 (90.9%) V124>L (103'), CDR-IMGT (5.3.9) (27'-31'.49'-51'.88'-96')) (1'-106') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (152'), V101 (190')) (107'-213')); DIMER (227-227'':230-230'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, DERIVED FROM THE CELL LINE CHO-K1, LACKING THE GLUTAMINE SYNTHETASE (GS-KO) GENE, GLYCOFORM ALFA

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN-MUS MUSCULUS MONOCLONAL SSGJ-613 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SSGJ-613 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL1B (INTERLEUKIN 1 BETA, IL-1B, 1L1F2)), MONOCLONAL ANTIBODY (ANFLEKITUG)

External Clinical & Regulatory Resources

Previous UNIIZB7QD52SWF

Next UNIIZB859O2CNL